With 1.6 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.38 million shares. The 52-week range on THC shows that it touched its highest point at $171.20 and its lowest point at $88.98 during that stretch. It currently has a 1-year price target of $173.53. Beta for the stock currently stands at 2.06.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of THC was down-trending over the past week, with a drop of -1.31%, but this was down by -4.87% over a month. Three-month performance dropped to -14.21% while six-month performance fell -16.85%. The stock gained 43.84% in the past year, while it has gained 4.22% so far this year. A look at the trailing 12-month EPS for THC yields 32.23 with Next year EPS estimates of 13.08. For the next quarter, that number is 3.17. This implies an EPS growth rate of 1.94% for this year and 7.97% for next year.
Float and Shares Shorts:
At present, 95.11 million THC shares are outstanding with a float of 92.94 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for THC since 10 analysts follow the stock currently. There are 9 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $11.46073 being high and $11.13214 being low. For THC, this leads to a yearly average estimate of $11.32133.
